17 alpha-hydroxyprogesterone caproate has been researched along with estradiol 3-benzoate in 1 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (estradiol 3-benzoate) | Trials (estradiol 3-benzoate) | Recent Studies (post-2010) (estradiol 3-benzoate) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 1,051 | 79 | 338 |
| Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | estradiol 3-benzoate (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.065 | |
| Glucocorticoid receptor | Homo sapiens (human) | 5.074 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 5.074 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.01 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 5.074 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 5.074 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 5.074 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.672 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chepick, OF | 1 |
1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and estradiol 3-benzoate
| Article | Year |
|---|---|
Morphological aspects of the hormone-induced pathomorphosis of endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Antineoplastic Agents; Cell Division; Chemotherapy, Adjuvant; Clomiphene; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Enzymes; Estradiol; Female; Glycogen; Humans; Hydroxyprogesterones; Microscopy, Electron; Neoplasm Staging; Neoplasms, Hormone-Dependent; Remission Induction | 1993 |